Related Experiment Videos
Conversion of mdx myofibres from dystrophin-negative to -positive by injection of normal myoblasts
T A Partridge1, J E Morgan, G R Coulton
1Department of Histopathology, Charing Cross and Westminster Medical School, London, UK.
Abstract:
An important corollary to the recent advances in our understanding of the primary cause of Duchenne muscular dystrophy, is the validation of genuine genetic homologues as animal models of the disease in which potential therapies can be tested. The persistent skeletal muscle necrosis that characterizes human Duchenne muscular dystrophy is also seen in the mdx mouse and is, in both, a consequence of a deficiency of dystrophin, probably within the muscle fibres themselves. As injected muscle precursor cells of one genotype can fuse with host muscle fibres of a different genotype and express the donor genes, we decided to test grafts of normal muscle precursor cells to see if they could induce synthesis of dystrophin in innately dystrophin-deficient mdx muscle fibres. We show that injected normal muscle precursor cells can fuse with pre-existing or regenerating mdx muscle fibres to render many of these fibres dystrophin-positive and so to partially or wholly rescue them from their biochemical defect.
Insights
Normal muscle precursor cell grafts can fuse with dystrophin-deficient mdx mouse muscle fibers. This fusion leads to dystrophin production, partially or fully rescuing these muscle fibers from their defect.
Area of Science:
- Biomedical Science
- Genetics
- Regenerative Medicine
Background:
- Duchenne muscular dystrophy (DMD) is characterized by skeletal muscle necrosis.
- The mdx mouse is a genetic homologue model for DMD, exhibiting similar muscle pathology due to dystrophin deficiency.
- Muscle precursor cells can integrate with host muscle fibers, expressing donor genes.
Purpose of the Study:
- To investigate if normal muscle precursor cell grafts can induce dystrophin synthesis in dystrophin-deficient mdx muscle fibers.
- To evaluate the potential of cell transplantation as a therapeutic strategy for Duchenne muscular dystrophy.
Main Methods:
- Grafting of normal muscle precursor cells into mdx mice.
- Analysis of dystrophin expression in host muscle fibers post-transplantation.
- Assessment of muscle fiber rescue from dystrophin deficiency.
Main Results:
- Injected normal muscle precursor cells successfully fused with existing and regenerating mdx muscle fibers.
- A significant number of mdx muscle fibers became dystrophin-positive following transplantation.
- Partial or complete rescue of dystrophin-deficient muscle fibers was observed.
Conclusions:
- Cell fusion therapy demonstrates potential for treating Duchenne muscular dystrophy by restoring dystrophin.
- Muscle precursor cell transplantation can partially or wholly correct the biochemical defect in dystrophin-deficient muscle.
- This study validates genetic homologue models for testing potential therapies for DMD.